FDA is investigating reports from over 100 consumers who reported experiencing nausea, vomiting, and diarrhea after eating Lucky Charms cereal, in today's bite-sized hospital and health industry news from the District of Columbia, Maryland, Minnesota, and Washington.

• District of Columbia: The Supreme Court on Monday upheld the Pentagon's disciplinary action against Air Force Reserve lieutenant colonel Jonathan Dunn, who was removed from command after he refused to comply with its Covid-19 vaccine mandate. Dunn requested emergency relief to shield himself from "further punishment, including a discharge," after he refused the vaccine on religious objections. In response, U.S. Solicitor General Elizabeth Prelogar said that "the Air Force has a compelling interest in requiring applicant to be as medically and physically prepared for deployment with his reserve unit as possible, particularly because his unit is designed to be deployable worldwide with just 72 hours' notice." The court's unsigned order did not provide any reasoning, but it did note that Justices Clarence Thomas, Samuel Alito, and Neil Gorsuch dissented with the decision to deny Dunn's application for an injunction. (Chen, Axios, 4/18)

• Maryland/Minnesota: FDA officials said they are investigating reports from consumers who said they became ill after eating General Mills' Lucky Charms cereal. The agency received over 100 reports from consumers who said they experienced nausea, diarrhea, and vomiting after eating the cereal. General Mills is currently working with FDA on the investigation and has not recalled the product. The company's internal investigation found no evidence of illnesses tied to the cereal. However, Patrick Quade, founder of consumer website iwaspoisoned.com, on Sunday said his site has received around 3,000 reports in 2022 from consumers saying they became ill after eating the cereal—the highest number of complaints any product on the site has ever received. Notably, most of the site's reports have come in during the past two weeks. (Gasparro, Wall Street Journal, 4/17; Choi, The Hill, 4/17)

• Washington: UW Medicine on April 8 announced the departure of CEO Paul Ramsey, who will retire this summer. According to the announcement, Ramsey will step down from his administrative position as CEO of UW Medicine and dean of the University of Washington School of Medicine on June 30. On July 31, he will retire from the University of Washington. UW Medicine CMO Tim Dellit will act as interim CEO for the next two years. "Why have I decided to retire this summer? The short answer is that the time is right," Ramsey said. "I have always hoped that my retirement would coincide with UW Medicine being in a strong position to lead changes in medicine: today it is." (Gooch, Becker's Hospital Review, 4/15)